SCHEMBL13624588

SCHEMBL13624588

COc1ccc2c(c1)oc1c(C)c(C#N)c(=O)[nH]c12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALPL P05186 2/20 0.47
ALPI P09923 2/20 0.47
KDM4E B2RXH2 4/20 0.45
ALDH1A1 P00352 4/20 0.45
HPGD P15428 2/20 0.45
HSD17B10 Q99714 2/20 0.45
GAA P10253 1/20 0.45
RAB9A P51151 3/20 0.45
POLB P06746 2/20 0.45
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
PPARG P37231 1/20 0.45
NCOA2 Q15596 1/20 0.45
NCOA1 Q15788 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
ADORA2A P29274 1/20 0.43
NPC1 O15118 2/20 0.43
MAPT P10636 1/20 0.43
STAT1 P42224 1/20 0.43
MAOA P21397 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13624582 0.80 ALDH1A1 (0.46) KDM4EALDH1A1HPGDHSD17B10GAA
SCHEMBL5470345 0.76 RAB9A (0.58) KDM4EALDH1A1HPGDHSD17B10RAB9A
SCHEMBL15842341 0.76 ALPL (0.74) ALPLALPIKDM4EALDH1A1HPGD
SCHEMBL16695703 0.76 KDM4E (0.54) ALPLALPIKDM4EALDH1A1HPGD
SCHEMBL4657752 0.73 ALPL (0.41) ALPLALPIKDM4EALDH1A1HPGD
SCHEMBL11397024 0.72 KDM4E (0.60) ALPLALPIKDM4EALDH1A1HPGD
SCHEMBL11750821 0.69 CA1 (0.61) ALPLALPIKDM4EALDH1A1HPGD
SCHEMBL13624584 0.68 PDE9A (0.46) KDM4EGAA
SCHEMBL17284920 0.68 KMT2A (0.68) KDM4EALDH1A1HPGDHSD17B10RAB9A
SCHEMBL2284104 0.68 KDM4E (0.57) KDM4EALDH1A1HPGDHSD17B10GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7622582-B2 Derivatives of 1-phenyl-benzofuro[3,2]pyridin-2(1H)-one TIBOTEC BVBA (BE) 2009-11-24 US disclosed
US-7622582-B2 Derivatives of 1-phenyl-benzofuro[3,2]pyridin-2(1H)-one TIBOTEC BVBA (BE) 2009-11-24 US disclosed
US-20070213320-A1 4-SUBSTITUTED-1,5-DIHYDRO-PYRIDO[3,2-B]INDOL-2-ONES TIBOTEC BVBA (BE) 2007-09-13 US disclosed
US-20070213320-A1 4-SUBSTITUTED-1,5-DIHYDRO-PYRIDO[3,2-B]INDOL-2-ONES TIBOTEC BVBA (BE) 2007-09-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070213320-A1 4-SUBSTITUTED-1,5-DIHYDRO-PYRIDO[3,2-B]INDOL-2-ONES NR2C2, CYP4B1, OXER1 ALPL 4679/4885ALPI 4752/4885KDM4E 3819/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.